VYNE Therapeutics Inc VYNE Price Prediction

The determination to procure VYNE Therapeutics Inc is entirely contingent on your individualistic risk tolerance. As you may discern, VYNE Therapeutics Inc's value has experienced a fall of 0% during the preceding 24 hours, and VYNE Therapeutics Inc has incurred a decline of  over the prior 30-day duration. Consequently, the determination of whether or not to invest in VYNE Therapeutics Inc will hinge on whether such an investment aligns with your trading aspirations.

It appears that the mean value of VYNE Therapeutics Inc may potentially surge to $31.72 by the end of this year. Looking at VYNE Therapeutics Inc's prospects in a more extended five-year timeline, the stock could potentially growth to as much as $30.39. However, given the market's unpredictability, it is vital to conduct thorough research before investing any funds into a particular company or asset.

Based on the our new experimental VYNE Therapeutics Inc forecast, the price of VYNE Therapeutics Inc will fall by -1.12% over the next week and reach $28.24 by October 15, 2026.

Based on the our new experimental VYNE Therapeutics Inc forecast, the price of VYNE Therapeutics Inc will increase by 8.73% over the next month and reach $31.05 by November 7, 2026.

As per our most recent prediction on VYNE Therapeutics Inc's value in 2026, VYNE is anticipated to fluctuate within the range of $28.23 and $31.72. However, it is crucial to bear in mind that the stock market is exceptionally unstable, and this projected VYNE Therapeutics Inc price forecast fails to consider sudden and extreme price fluctuations.

VYNE Therapeutics Inc's future appears to be on an upward trend, with an maximum price of $30.39 projected after a period of five years. Based on the VYNE Therapeutics Inc forecast for 2031, VYNE Therapeutics Inc's value may potentially reach its highest peak of approximately $30.39, while its lowest peak is anticipated to be around $26.85.

Based on the our new experimental VYNE Therapeutics Inc price prediction simulation, VYNE’s value in 2026 expected to grow by 11.09% to $31.72 if the best happened. The price will be between $31.72 and $28.23 during 2026.

According to our latest experimental simulation for VYNE Therapeutics Inc price prediction, VYNE’s value could rise by 17.47% to $33.54 in 2027, assuming the most favorable conditions. The price is projected to fluctuate between $33.54 and $25.11 throughout the year.

Our new experimental VYNE Therapeutics Inc price prediction model suggests that VYNE’s value in 2028 could down by -5.53%, reaching $26.97 in the best-case scenario. The price is expected to range between $26.97 and $19.22 during the year.

Based on our experimental forecast model, VYNE Therapeutics Inc's value may experience a -16.38% fall in 2029, potentially reaching $23.88 under optimal conditions. The predicted price range for 2029 lies between $23.88 and $19.56.

Using our new experimental simulation for VYNE Therapeutics Inc price predictions, VYNE’s value in 2030 is expected to rise by 2.17% , reaching $29.18 in the best scenario. The price is forecasted to range between $29.18 and $20.77 over the course of 2030.

Our experimental simulation indicates that VYNE Therapeutics Inc’s price could grow by 6.41% in 2031, potentially hitting $30.39 under ideal conditions. The price will likely fluctuate between $30.39 and $26.85 during the year.

Based on the findings from our latest experimental VYNE Therapeutics Inc price prediction, VYNE could see a 31.65% rise in value, reaching $37.59 if the most positive scenario plays out in 2032. The price is expected to stay within a range of $37.59 and $29.42 throughout the year.

According to our experimental VYNE Therapeutics Inc price prediction, VYNE’s value is anticipated to rise by 75.73% in 2033, with the highest potential price being $50.18. Throughout the year, VYNE’s price could range from $50.18 and $37.68.

The results from our new VYNE Therapeutics Inc price prediction simulation suggest that VYNE may rise by 107.79% in 2034, potentially reaching $59.34 under the best circumstances. The predicted price range for the year is between $59.34 and $48.38.

Based on our experimental forecast for VYNE Therapeutics Inc’s price, VYNE could grow by 170.09% , with the value potentially hitting $77.13 in 2035. The expected price range for the year lies between $77.13 and $55.36.

Our recent VYNE Therapeutics Inc price prediction simulation suggests that VYNE’s value might rise by 290.85% in 2036, possibly reaching $111.62 if conditions are optimal. The expected price range for 2036 is between $111.62 and $72.85.

According to the experimental simulation, VYNE Therapeutics Inc’s value could rise by 420.82% in 2037, with a high of $148.74 under favorable conditions. The price is expected to fall between $148.74 and $109.14 over the course of the year.